98 related articles for article (PubMed ID: 10442373)
61. Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).
Nakayama T; Sagara Y; Takashima T; Matsunami N; Masuda N; Miyoshi Y; Taguchi T; Aono T; Ito T; Kagimura T; Noguchi S
Cancer Chemother Pharmacol; 2018 Apr; 81(4):755-762. PubMed ID: 29468454
[TBL] [Abstract][Full Text] [Related]
62. Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer.
Solé LA; Albanell J; Bellmunt J; Ribas A; Gallego OS; Carulla J
Cancer; 1995 Feb; 75(3):831-5. PubMed ID: 7828134
[TBL] [Abstract][Full Text] [Related]
63. Is there an advantage for oral therapy in elderly? UFT.
Labianca R; Beretta G; Mosconi S; Pessi MA
Tumori; 2002; 88(1 Suppl 1):S71-2. PubMed ID: 11989931
[No Abstract] [Full Text] [Related]
64. [Drug-induced liver injury associated with uracil/tegafur + folinate therapy].
Kawasaki A; Mimatsu K; Kuboi Y; Kano H; Oida T; Amano S
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1901-3. PubMed ID: 19920397
[TBL] [Abstract][Full Text] [Related]
65. [A case of breast cancer with thrombosis during treatment of lung metastasis].
Sakaguchi T; Watahiki Y; Kosaka A
Gan To Kagaku Ryoho; 1993 Mar; 20(4):525-8. PubMed ID: 8452390
[TBL] [Abstract][Full Text] [Related]
66. [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].
Endo F; Ishii T; Kito T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):851-4. PubMed ID: 2496670
[TBL] [Abstract][Full Text] [Related]
67. [The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer].
Nukatsuka M; Fujioka A; Nakagawa F; Ohshimo H; Kitazato K; Fukushima M
Gan To Kagaku Ryoho; 2002 May; 29(5):803-6. PubMed ID: 12040690
[No Abstract] [Full Text] [Related]
68. Association between
Kamio H; Uchiyama T; Kanno H; Onoe Y; Saito K; Kameoka S; Kamio T; Okamoto T
Pharmacogenomics; 2019 Apr; 20(5):353-365. PubMed ID: 30734632
[No Abstract] [Full Text] [Related]
69. [A case of metronomic chemotherapy as an alternative cancer therapy for palliation].
Yamashita K; Nabeshima A; Kondo H; Nagao T; Hara Y; Naritomi Y
Nihon Ronen Igakkai Zasshi; 2009 May; 46(3):264-8. PubMed ID: 19521048
[TBL] [Abstract][Full Text] [Related]
70. An Unusual Case of Acute Liver Failure Caused by Adjuvant Oral Tegafur-Uracil with Folinate Therapy for Colon Cancer Patient: a Case Report.
Hiraki M; Tanaka T; Koga F; Saito A; Oza N; Ikeda O; Manabe T; Miyoshi A; Kitahara K; Sato S; Noshiro H
J Gastrointest Cancer; 2020 Mar; 51(1):296-299. PubMed ID: 30903577
[No Abstract] [Full Text] [Related]
71. Oral tegafur in the treatment of metastatic breast cancer: a phase II study.
Kajanti MJ; Pyrhönen SO; Maiche AG
Eur J Cancer; 1993; 29A(6):863-6. PubMed ID: 8484979
[TBL] [Abstract][Full Text] [Related]
72. ASO Author Reflections: Tegafur-Uracil in Advanced Oral Cancer.
Hsieh MY; Chen MK
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):899-900. PubMed ID: 30374925
[No Abstract] [Full Text] [Related]
73. Erratum to: Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
World J Surg Oncol; 2017 Sep; 15(1):171. PubMed ID: 28915885
[No Abstract] [Full Text] [Related]
74. Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.
Antón A; Barnadas A; Florián J; Ribelles N; Lomas M; Lao J; González-Quintás A; Margelí M; Paules AB; Gayo J; Ramos M;
Clin Transl Oncol; 2011 Apr; 13(4):281-6. PubMed ID: 21493190
[TBL] [Abstract][Full Text] [Related]
75. Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.
Presant CA; Jacobson J; Wolf W; Waluch V; Weitz IC; Macdonald JS;
Invest New Drugs; 2002 Nov; 20(4):369-76. PubMed ID: 12448653
[TBL] [Abstract][Full Text] [Related]
76. Uracil/tegafur plus oral calcium folinate in advanced breast cancer.
Richardet E; Pedraza C; Mickiewicz E; Lerzo G; Bonamasa M; Coppola F; Elli A; Uranga G; Jovtis S; Bruno M; Ventriglia M; Cuevas MA; Alvarez AM; Suarez LA; Fein L
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):96-7. PubMed ID: 10442373
[TBL] [Abstract][Full Text] [Related]
77. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
[TBL] [Abstract][Full Text] [Related]
78. UFT plus oral calcium folinate/vinorelbine for advanced breast cancer.
Fumoleau P; Déporte-Fety R; Kerbrat P; Laguerre B
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):86-90. PubMed ID: 10442371
[TBL] [Abstract][Full Text] [Related]
79. UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
Lück HJ; Scholz U; Kühnle H; Dethling J
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):74-6. PubMed ID: 10442368
[TBL] [Abstract][Full Text] [Related]
80. Epirubicin, cyclophosphamide, and UFT plus oral calcium folinate in advanced breast cancer.
Smith IE
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):82-5. PubMed ID: 10442370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
